PREEMIE Reauthorization Act of 2023

The PREEMIE Reauthorization Act of 2023 extends federal funding for research and care related to preterm births and low birthweight infants through fiscal years 2024-2028, replacing previous funding periods. It updates existing programs to include screening for and treatment of chronic conditions in infant care and requires the Health and Human Services Secretary to establish an interagency working group within 18 months. The bill mandates a National Academies study to assess financial costs of preterm birth (including neonatal ICU stays and long-term family expenses), factors influencing birth rates, gaps in public health support, and research strategies for prevention, with a final report due within 24 months. This legislation directly affects federal health agencies, healthcare providers, and families caring for preterm infants by advancing evidence-based improvements in care.